HomeCompareIQDE vs JNJ

IQDE vs JNJ: Dividend Comparison 2026

IQDE yields 5.17% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IQDE wins by $8.1K in total portfolio value
10 years
IQDE
IQDE
● Live price
5.17%
Share price
$20.60
Annual div
$1.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.1K
Annual income
$718.68
Full IQDE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — IQDE vs JNJ

📍 IQDE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIQDEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IQDE + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IQDE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IQDE
Annual income on $10K today (after 15% tax)
$439.07/yr
After 10yr DRIP, annual income (after tax)
$610.88/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $92.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IQDE + JNJ for your $10,000?

IQDE: 50%JNJ: 50%
100% JNJ50/50100% IQDE
Portfolio after 10yr
$24.1K
Annual income
$773.23/yr
Blended yield
3.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IQDE
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IQDE buys
0
JNJ buys
0
No recent congressional trades found for IQDE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIQDEJNJ
Forward yield5.17%3.36%
Annual dividend / share$1.06$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$28.1K$20.0K
Annual income after 10y$718.68$827.78
Total dividends collected$6.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IQDE vs JNJ ($10,000, DRIP)

YearIQDE PortfolioIQDE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,217$516.56$10,676$355.77+$541.00IQDE
2$12,543$541.49$11,407$389.39+$1.1KIQDE
3$13,987$565.92$12,198$426.53+$1.8KIQDE
4$15,556$589.79$13,056$467.62+$2.5KIQDE
5$17,258$613.03$13,987$513.12+$3.3KIQDE
6$19,102$635.61$14,998$563.56+$4.1KIQDE
7$21,096$657.49$16,098$619.52+$5.0KIQDE
8$23,252$678.64$17,295$681.69+$6.0KIQDE
9$25,578$699.04$18,599$750.82+$7.0KIQDE
10$28,087$718.68$20,022$827.78+$8.1KIQDE

IQDE vs JNJ: Complete Analysis 2026

IQDEStock

The underlying index is designed to reflect the performance of a selection of companies that, in aggregate, possess greater financial strength and stability characteristics relative to the Northern Trust International Large Cap Index. The fund will invest at least 80% of its total assets in the securities of the underlying index and in ADRs and GDRs based on the securities in the underlying index.

Full IQDE Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this IQDE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IQDE vs SCHDIQDE vs JEPIIQDE vs OIQDE vs KOIQDE vs MAINIQDE vs ABBVIQDE vs MRKIQDE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.